These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 31510053

  • 41. The role of urine IgG in the progression of IgA nephropathy with a high proportion of global glomerulosclerosis.
    Xu X, Huang X, Chen Y, Li J, Shen M, Hou Y, Lin X, Lin Q, Liu X, Bao K, Wang L, Yang H, Liu L, Zou C.
    Int Urol Nephrol; 2022 Feb; 54(2):323-330. PubMed ID: 33871780
    [Abstract] [Full Text] [Related]

  • 42. Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status.
    Gong S, Jin S, Li Y, Jiang W, Zhang Z, Shen Z, Wang J, Zhou H, Liu X, Xu X, Ding X, Shi Y, Liu H.
    Front Immunol; 2021 Feb; 12():769802. PubMed ID: 35003086
    [Abstract] [Full Text] [Related]

  • 43. Clinical significance of urinary inflammatory biomarkers in patients with IgA nephropathy.
    Yoon SY, Kim JS, Jung SW, Kim YG, Moon JY, Lee SH, Yim SV, Hwang HS, Jeong K.
    BMC Nephrol; 2024 Apr 22; 25(1):142. PubMed ID: 38649936
    [Abstract] [Full Text] [Related]

  • 44. Urine podocyte mRNAs mark disease activity in IgA nephropathy.
    Fukuda A, Sato Y, Iwakiri T, Komatsu H, Kikuchi M, Kitamura K, Wiggins RC, Fujimoto S.
    Nephrol Dial Transplant; 2015 Jul 22; 30(7):1140-50. PubMed ID: 25956757
    [Abstract] [Full Text] [Related]

  • 45. IgA Nephropathy.
    Rodrigues JC, Haas M, Reich HN.
    Clin J Am Soc Nephrol; 2017 Apr 03; 12(4):677-686. PubMed ID: 28159829
    [Abstract] [Full Text] [Related]

  • 46. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy.
    Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM.
    Nephrol Dial Transplant; 2002 Jul 03; 17(7):1197-203. PubMed ID: 12105241
    [Abstract] [Full Text] [Related]

  • 47. A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.
    Lafayette RA, Canetta PA, Rovin BH, Appel GB, Novak J, Nath KA, Sethi S, Tumlin JA, Mehta K, Hogan M, Erickson S, Julian BA, Leung N, Enders FT, Brown R, Knoppova B, Hall S, Fervenza FC.
    J Am Soc Nephrol; 2017 Apr 03; 28(4):1306-1313. PubMed ID: 27821627
    [Abstract] [Full Text] [Related]

  • 48. Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.
    Niu X, Zhang S, Shao C, Guo Z, Wu J, Tao J, Zheng K, Ye W, Cai G, Sun W, Li M.
    PeerJ; 2023 Apr 03; 11():e15125. PubMed ID: 37065697
    [Abstract] [Full Text] [Related]

  • 49. The Value of Serum IgA in the Diagnosis, Clinical and Pathological Evaluation of Patients with IgA Nephropathy Found During Physical Examination in China.
    Ren L, Zhang C, Pan Y, Sun J.
    Clin Lab; 2019 Dec 01; 65(12):. PubMed ID: 31850707
    [Abstract] [Full Text] [Related]

  • 50. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy.
    Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, Haller H, Mischak H.
    Kidney Int; 2005 Jun 01; 67(6):2313-20. PubMed ID: 15882273
    [Abstract] [Full Text] [Related]

  • 51. Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys.
    Taylor S, Pieri K, Nanni P, Tica J, Barratt J, Didangelos A.
    J Autoimmun; 2019 Dec 01; 105():102309. PubMed ID: 31402200
    [Abstract] [Full Text] [Related]

  • 52. Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.
    Neuhaus J, Bauer F, Fitzner C, Hilgers RD, Seibert F, Babel N, Doevelaar A, Eitner F, Floege J, Rauen T, Westhoff TH.
    Kidney Blood Press Res; 2018 Dec 01; 43(5):1563-1572. PubMed ID: 30347407
    [Abstract] [Full Text] [Related]

  • 53. Clinical significance of urinary tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in immunoglobulin A nephropathy
.
    Kim JS, Jeong KH.
    Clin Nephrol; 2020 Feb 01; 93(2):99-105. PubMed ID: 31829928
    [Abstract] [Full Text] [Related]

  • 54. Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation.
    Garnier AS, Duveau A, Demiselle J, Croué A, Subra JF, Sayegh J, Augusto JF.
    PLoS One; 2018 Feb 01; 13(4):e0196101. PubMed ID: 29694420
    [Abstract] [Full Text] [Related]

  • 55. Urinary CXCL1: a novel predictor of IgA nephropathy progression.
    Zhao Y, Zhu L, Zhou T, Zhang Q, Shi S, Liu L, Lv J, Zhang H.
    PLoS One; 2015 Feb 01; 10(3):e0119033. PubMed ID: 25816025
    [Abstract] [Full Text] [Related]

  • 56. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
    Yu GZ, Guo L, Dong JF, Shi SF, Liu LJ, Wang JW, Sui GL, Zhou XJ, Xing Y, Li HX, Lv JC, Zhang H.
    Am J Kidney Dis; 2020 Jul 01; 76(1):90-99. PubMed ID: 32197881
    [Abstract] [Full Text] [Related]

  • 57. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S, Li JP.
    Trials; 2020 Jan 06; 21(1):31. PubMed ID: 31907076
    [Abstract] [Full Text] [Related]

  • 58. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J, Peng T, Gao J, Jia X, Yan G, Wang Y.
    BMC Immunol; 2018 Jun 20; 19(1):18. PubMed ID: 29925312
    [Abstract] [Full Text] [Related]

  • 59. A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity.
    Han QX, Wang Y, Zhu HY, Zhang D, Gao J, Liu ZS, Cai GY, Chen XM.
    Chin Med J (Engl); 2019 Mar 20; 132(6):647-652. PubMed ID: 30855344
    [Abstract] [Full Text] [Related]

  • 60. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
    Liu D, You J, Liu Y, Tang X, Tan X, Xia M, Wu L, Chen G, He L, Zhu X, Liu H.
    Int Immunopharmacol; 2019 Jan 20; 66():13-18. PubMed ID: 30415190
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.